{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T18:49:27Z","timestamp":1743101367357,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":146,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642307256"},{"type":"electronic","value":"9783642307263"}],"license":[{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T00:00:00Z","timestamp":1346803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-642-30726-3_15","type":"book-chapter","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T11:24:11Z","timestamp":1349090651000},"page":"307-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Obesity and Diabetes"],"prefix":"10.1007","author":[{"given":"Alexandra","family":"Kautzky-Willer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Lemmens-Gruber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejphar.2005.08.019","volume":"521","author":"B Ahr\u00e9n","year":"2005","unstructured":"Ahr\u00e9n B, S\u00f6rhede Winzell M, Burkey B, Hughes TE (2005) Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice. Eur J Pharmacol 521:164\u2013168. doi:10.1016\/j.ejphar.2005.08.019","journal-title":"Eur J Pharmacol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10557-007-6047-x","volume":"21","author":"F Akar","year":"2007","unstructured":"Akar F, Manavbasi Y, Parlar AI, Ulus AT, Katircioglu SF (2007) The gender differences in the relaxation to levosimendan of human internal mammary artery. Cardiovasc Drugs Ther 21:331\u2013338. doi:10.1007\/s10557-007-6047-x","journal-title":"Cardiovasc Drugs Ther"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/pds.1896","volume":"19","author":"MO Amundsen","year":"2010","unstructured":"Amundsen MO, Engdahl B, Berg C, Nordeng H (2010) Use of psychotropic drugs and analgesics among users of antiobesity drugs \u2013 a population based study. Pharmacoepidemiol Drug Saf 19:273\u2013279. doi:10.1002\/pds.1896","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/jc.2010-1398","volume":"96","author":"C Anderwald","year":"2011","unstructured":"Anderwald C, Gastaldelli A, Tura A, Krebs M, Promintzer-Schifferl M, Kautzky-Willer A, Stadler M, DeFronzo RA, Pacini G, Bischof MG (2011) Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab 96:515\u2013524. doi:10.1210\/jc.2010-1398","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR5","first-page":"945","volume":"2","author":"VN Anisimov","year":"2010","unstructured":"Anisimov VN, Piskunova TS, Popovich IG, Zabezhinski MA, Tyndyk ML, Egormin PA, Yurova MV, Rosenfeld SV, Semenchenko AV, Kovalenko IG, Poroshina TE, Berstein LM (2010) Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129\/Sv mice. Aging (Albany NY) 2:945\u2013958. doi:100245[pii]","journal-title":"Aging (Albany NY)"},{"key":"15_CR6","first-page":"148","volume":"3","author":"VN Anisimov","year":"2011","unstructured":"Anisimov VN, Berstein LM, Popovich IG, Zabezhinski MA, Egormin PA, Piskunova TS, Semenchenko AV, Tyndyk ML, Yurova MN, Kovalenko IG, Poroshina TE (2011) If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany NY) 3:148\u2013157. doi:100273[pii]","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"15_CR7","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1177\/0091270010388651","volume":"51","author":"JW Bae","year":"2011","unstructured":"Bae JW, Jang CG, Lee SY (2011) Effects of clopidogrel on the pharmacokinetics of sibutramine and its active metabolites. J Clin Pharmacol 51(12):1704\u20131711. doi:10.1177\/0091270010388651","journal-title":"J Clin Pharmacol"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1365-2265.2008.03459.x","volume":"70","author":"M Barba","year":"2009","unstructured":"Barba M, Sch\u00fcnemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P (2009) The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 70:661\u2013670. doi:10.1111\/j.1365-2265.2008.03459.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"15_CR9","doi-asserted-by":"publisher","unstructured":"Bayraktar S, Hernadez-Aya LF, Lei X, Meric-Bernstam F, Litton JK, Hsu L, Hortobagyi GN, Gonzalez-Angulo AM (2011) Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer. Cancer. doi:10.1002\/cncr.26439","DOI":"10.1002\/cncr.26439"},{"issue":"6","key":"15_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2164\/jandrol.111.013466","volume":"32","author":"FF Bellentani","year":"2011","unstructured":"Bellentani FF, Fernandes GS, Perobelli JE, Pacini ES, Kiguti LR, Pupo AS, Kempinas WD (2011) Acceleration of sperm transit time and reduction of sperm reserves in the epididymis of rats exposed to sibutramine. J Androl 32(6):718\u2013724. doi:10.2164\/jandrol.111.013466","journal-title":"J Androl"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/DDDT.S11859","volume":"5","author":"NT Bello","year":"2011","unstructured":"Bello NT, Liang NC (2011) The use of serotonergic drugs to treat obesity\u2013is there any hope? Drug Des Devel Ther 5:95\u2013109. doi:10.2147\/DDDT.S11859","journal-title":"Drug Des Devel Ther"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1124\/mol.63.4.908","volume":"63","author":"M Bensaid","year":"2003","unstructured":"Bensaid M, Gary-Bobo M, Esclangon A, Maffrand JP, Le Fur G, Oury-Donat F, Soubrie P (2003) The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells. Mol Pharmacol 63:908\u2013914. doi:10.1124\/mol.63.4.908","journal-title":"Mol Pharmacol"},{"key":"15_CR13","volume-title":"Sex and gender differences in pharmacology","author":"V Benz","year":"2012","unstructured":"Benz V, Kintscher U, Foryst-Ludwig A (2012) Sex-specific differences in Type 2 Diabetes Mellitus and dyslipidemia therapy: PPAR agonists. In: Regitz-Zagrosek V (ed) Sex and gender differences in pharmacology. Springer, Heidelberg"},{"key":"15_CR14","first-page":"386","volume":"147","author":"S Bolen","year":"2007","unstructured":"Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, Wiley C, Selvin E, Wilson R, Bass EB, Brancati FL (2007) Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med 147:386\u2013399. doi:0000605-200709180-00178[pii]","journal-title":"Ann Intern Med"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2165\/11584350-000000000-00000","volume":"50","author":"DW Boulton","year":"2011","unstructured":"Boulton DW, Li L, Frevert EU, Tang A, Castaneda L, Vachharajani NN, Kornhauser DM, Patel CG (2011) Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin. Clin Pharmacokinet 50:253\u2013265. doi:10.2165\/11584350-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejphar.2011.02.021","volume":"658","author":"CM Boustany-Kari","year":"2011","unstructured":"Boustany-Kari CM, Jackson VM, Gibbons CP, Swick AG (2011) Leptin potentiates the anti-obesity effects of rimonabant. Eur J Pharmacol 658:270\u2013276. doi:10.1016\/j.ejphar.2011.02.021","journal-title":"Eur J Pharmacol"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.diabet.2010.03.009","volume":"36","author":"M Buysschaert","year":"2010","unstructured":"Buysschaert M, Preumont V, Oriot PR, Paris I, Ponchon M, Scarniere D, Selvais P (2010) One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice. Diabetes Metab 36:381\u2013388. doi:10.1016\/j.diabet.2010.03.009","journal-title":"Diabetes Metab"},{"issue":"Suppl 2","key":"15_CR18","doi-asserted-by":"publisher","first-page":"S264","DOI":"10.2337\/dc11-s223","volume":"34","author":"S Cernea","year":"2011","unstructured":"Cernea S, Raz I (2011) Therapy in the early stage: incretins. Diabetes Care 34(Suppl 2):S264\u2013S271. doi:10.2337\/dc11-s223","journal-title":"Diabetes Care"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","volume":"359","author":"JL Chiasson","year":"2002","unstructured":"Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072\u20132077. doi:10.1016\/S0140-6736(02)08905-5","journal-title":"Lancet"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","volume":"370","author":"R Christensen","year":"2007","unstructured":"Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706\u20131713. doi:10.1016\/S0140-6736(07)61721-8","journal-title":"Lancet"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","volume":"10","author":"AM Clark","year":"1995","unstructured":"Clark AM, Ledger W, Galletly C, Tomlinson L, Blaney F, Wang X, Norman RJ (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705\u20132712","journal-title":"Hum Reprod"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","volume":"13","author":"AM Clark","year":"1998","unstructured":"Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ (1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13:1502\u20131505","journal-title":"Hum Reprod"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581\u2013588. doi:10.1056\/NEJM199708283370901","journal-title":"N Engl J Med"},{"key":"15_CR24","doi-asserted-by":"publisher","unstructured":"Curioni C, Andre C (2006) Rimonabant for overweight or obesity. Cochrane Database Syst Rev: CD006162. 10.1002\/14651858.CD006162.pub2","DOI":"10.1002\/14651858.CD006162.pub2"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","volume":"52","author":"CJ Currie","year":"2009","unstructured":"Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766\u20131777. doi:10.1007\/s00125-009-1440-6","journal-title":"Diabetologia"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00213-005-0212-3","volume":"185","author":"GL Dalton","year":"2006","unstructured":"Dalton GL, Lee MD, Kennett GA, Dourish CT, Clifton PG (2006) Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse. Psychopharmacology (Berl) 185:45\u201357. doi:10.1007\/s00213-005-0212-3","journal-title":"Psychopharmacology (Berl)"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2337\/diacare.27.5.1077","volume":"27","author":"T Damci","year":"2004","unstructured":"Damci T, Yalin S, Balci H, Osar Z, Korugan U, Ozyazar M, Ilkova H (2004) Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients. Diabetes Care 27:1077\u20131080. doi:10.2337\/diacare.27.5.1077","journal-title":"Diabetes Care"},{"key":"15_CR28","doi-asserted-by":"publisher","unstructured":"de Oliveira Baraldi C, Lanchote VL, de Jesus AN, de Jesus Ponte Carvalho TM, Dantes Mois\u00e9s EC, Duarte G, Cavalli RC (2011) Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome. Eur J Clin Pharmacol. doi:10.1007\/s00228-011-1053-0","DOI":"10.1007\/s00228-011-1053-0"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.numecd.2004.07.002","volume":"15","author":"G de Simone","year":"2005","unstructured":"de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio PU, Pasanisi F (2005) Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects. Nutr Metab Cardiovasc Dis 15:24\u201330. doi:10.1016\/j.numecd.2004.07.002","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bpobgyn.2010.10.002","volume":"25","author":"HW de Valk","year":"2011","unstructured":"de Valk HW, Visser GH (2011) Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol 25:65\u201376. doi:S1521-6934(10)00125-2[pii]10.1016\/j.bpobgyn.2010.10.002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1210\/jc.2011-0246","volume":"96","author":"RA Defronzo","year":"2011","unstructured":"Defronzo RA, Abdul-Ghani MA (2011) Preservation of {beta}-cell function: the key to diabetes prevention. J Clin Endocrinol Metab 96:2354\u20132366. doi:jc.2011-0246[pii]10.1210\/jc.2011-0246","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejphar.2010.11.015","volume":"651","author":"G Derosa","year":"2011","unstructured":"Derosa G, Maffioli P, Ferrari I, Fogari E, D\u2019Angelo A, Palumbo I, Randazzo S, Bianchi L, Cicero AF (2011) Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load. Eur J Pharmacol 651:240\u2013250. doi:10.1016\/j.ejphar.2010.11.015","journal-title":"Eur J Pharmacol"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa044537","volume":"353","author":"JP Despres","year":"2005","unstructured":"Despres JP, Golay A, Sjostrom L (2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353:2121\u20132134. doi:10.1056\/NEJMoa044537","journal-title":"N Engl J Med"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V Di Marzo","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822\u2013825. doi:10.1038\/35071088","journal-title":"Nature"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2265.2006.02693.x","volume":"66","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D (2007) Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 66:103\u2013109. doi:10.1111\/j.1365-2265.2006.02693.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1001\/archinte.163.17.2058","volume":"163","author":"JB Dixon","year":"2003","unstructured":"Dixon JB, Dixon ME, O\u2019Brien PE (2003) Depression in association with severe obesity: changes with weight loss. Arch Intern Med 163:2058\u20132065. doi:10.1001\/archinte.163.17.2058","journal-title":"Arch Intern Med"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00125-010-1748-2","volume":"53","author":"SZ Duan","year":"2010","unstructured":"Duan SZ, Usher MG, Foley ELT, Milstone DS, Brosius FC 3rd, Mortensen RM (2010) Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice. Diabetologia 53:1493\u20131505. doi:10.1007\/s00125-010-1748-2","journal-title":"Diabetologia"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00125-011-2061-4","volume":"54","author":"AB El-Remessy","year":"2011","unstructured":"El-Remessy AB, Rajesh M, Mukhopadhyay P, Horv\u00e1th B, Patel V, Al-Gayyar MM, Pillai BA, Pacher P (2011) Cannabinoid 1 receptor activation contributes to vascular inflammation and cell death in a mouse model of diabetic retinopathy and a human retinal cell line. Diabetologia 54:1567\u20131578. doi:10.1007\/s00125-011-2061-4","journal-title":"Diabetologia"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00125-006-0176-9","volume":"49","author":"JM Evans","year":"2006","unstructured":"Evans JM, Ogston SA, Emslie-Smith A, Morris AD (2006) Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930\u2013936. doi:10.1007\/s00125-006-0176-9","journal-title":"Diabetologia"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1365-2125.2009.03522.x","volume":"68","author":"BC Field","year":"2009","unstructured":"Field BC, Chaudhri OB, Bloom SR (2009) Obesity treatment: novel peripheral targets. Br J Clin Pharmacol 68:830\u2013843. doi:10.1111\/j.1365-2125.2009.03522.x","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3810\/pgm.2010.05.2138","volume":"122","author":"R Frederich","year":"2010","unstructured":"Frederich R, Alexander JH, Fiedorek FT, Donovan M, Berglind N, Harris S, Chen R, Wolf R, Mahaffey KW (2010) A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes. Postgrad Med 122:16\u201327. doi:10.3810\/pgm.2010.05.2138","journal-title":"Postgrad Med"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","volume":"377","author":"KM Gadde","year":"2011","unstructured":"Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW (2011) Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet 377:1341\u20131352. doi:10.1016\/S0140-6736(11)60205-5","journal-title":"Lancet"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1113\/jphysiol.2008.164152","volume":"587","author":"AS Garfield","year":"2009","unstructured":"Garfield AS, Heisler LK (2009) Pharmacological targeting of the serotonergic system for the treatment of obesity. J Physiol 587:49\u201360. doi:10.1113\/jphysiol.2008.164152","journal-title":"J Physiol"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.rbmo.2010.11.006","volume":"22","author":"A Germeyer","year":"2011","unstructured":"Germeyer A, Jauckus J, Zorn M, Toth B, Capp E, Strowitzki T (2011) Metformin modulates IL-8, IL-1beta, ICAM and IGFBP-1 expression in human endometrial stromal cells. Reprod Biomed Online 22:327\u2013334. doi:10.1016\/j.rbmo.2010.11.006","journal-title":"Reprod Biomed Online"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545\u20132559. doi:10.1056\/NEJMoa0802743","journal-title":"N Engl J Med"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10815-011-9564-2","volume":"28","author":"S Ghandi","year":"2011","unstructured":"Ghandi S, Aflatoonian A, Tabibnejad N, Moghaddam MH (2011) The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study. J Assist Reprod Genet 28:591\u2013596. doi:10.1007\/s10815-011-9564-2","journal-title":"J Assist Reprod Genet"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diabetes.54.4.1245","volume":"54","author":"KM Gillespie","year":"2005","unstructured":"Gillespie KM, Nolsoe R, Betin VM, Kristiansen OP, Bingley PJ, Mandrup-Poulsen T, Gale EA (2005) Is puberty an accelerator of type 1 diabetes in IL6-174CC females? Diabetes 54:1245\u20131248. doi:54\/4\/1245[pii]","journal-title":"Diabetes"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S0004-27302009000200017","volume":"53","author":"AF Godoy-Matos","year":"2009","unstructured":"Godoy-Matos AF, Guedes EP, Souza LL, Martins MF (2009) Management of obesity in adolescents: state of art. Arq Bras Endocrinol Metabol 53:252\u2013261. doi:S0004-27302009000200017[pii]","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/oby.2005.208","volume":"13","author":"A Golay","year":"2005","unstructured":"Golay A, Laurent-Jaccard A, Habicht F, Gachoud JP, Chabloz M, Kammer A, Schutz Y (2005) Effect of orlistat in obese patients with binge eating disorder. Obes Res 13:1701\u20131708. doi:10.1038\/oby.2005.208","journal-title":"Obes Res"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1059\/0003-4819-154-10-201105170-00007","volume":"154","author":"JL Gross","year":"2011","unstructured":"Gross JL, Kramer CK, Leit\u00e4o CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ (2011) Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med 154:672\u2013679. doi:10.1059\/0003-4819-154-10-201105170-00007","journal-title":"Ann Intern Med"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1055\/s-0028-1128145","volume":"41","author":"DC Guzman","year":"2009","unstructured":"Guzman DC, Ruiz NL, Garcia EH, Mejia GB, Tellez PP, Jimenez GE, De la Rosa AM, Olguin HJ (2009) Effect of sibutramine on Na+, K+ ATPase activity and tryptophan levels on male and female rat brain. Horm Metab Res 41:363\u2013367. doi:10.1055\/s-0028-1128145","journal-title":"Horm Metab Res"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1210\/jc.2009-1385","volume":"95","author":"ZA Habib","year":"2010","unstructured":"Habib ZA, Havstad SL, Wells K, Divine G, Pladevall M, Williams LK (2010) Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95:592\u2013600. doi:10.1210\/jc.2009-1385","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 2","key":"15_CR53","doi-asserted-by":"publisher","first-page":"S349","DOI":"10.2337\/dc11-s255","volume":"34","author":"V Hainer","year":"2011","unstructured":"Hainer V (2011) Comparative efficiency and safety of pharmacological approaches to the management of obesity. Diabetes Care 34(Suppl 2):S349\u2013S354. doi:10.2337\/dc11-s255","journal-title":"Diabetes Care"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1185\/03007995.2010.485881","volume":"26","author":"S Halimi","year":"2010","unstructured":"Halimi S, Raccah D, Schweizer A, Dejager S (2010) Role of vildagliptin in managing type 2 diabetes mellitus in the elderly. Curr Med Res Opin 26:1647\u20131656. doi:10.1185\/03007995.2010.485881","journal-title":"Curr Med Res Opin"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0195-668X(03)00468-8","volume":"25","author":"M Hanefeld","year":"2004","unstructured":"Hanefeld M, Cagatay M, Petrowitsch T, Neuser D, Petzinna D, Rupp M (2004) Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 25:10\u201316. doi:S0195668X03004688[pii]","journal-title":"Eur Heart J"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2125.2007.03031.x","volume":"65","author":"YL He","year":"2008","unstructured":"He YL, Sabo R, Campestrini J, Wang Y, Riviere GJ, Nielsen JC, Rosenberg M, Ligueros-Saylan M, Howard D, Dole WP (2008) The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers. Br J Clin Pharmacol 65:338\u2013346. doi:10.1111\/j.1365-2125.2007.03031.x","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359:1577\u20131589. doi:10.1056\/NEJMoa0806470","journal-title":"N Engl J Med"},{"key":"15_CR58","doi-asserted-by":"publisher","unstructured":"Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A (2007) Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev: CD005613. 10.1002\/14651858.CD005613.pub3","DOI":"10.1002\/14651858.CD005613.pub3"},{"key":"15_CR59","doi-asserted-by":"publisher","unstructured":"Hsia Y, Dawoud D, Sutcliffe AG, Viner RM, Kinra S, Wong IC (2011) Unlicensed use of metformin in children and adolescents in UK. Br J Clin Pharmacol. doi:10.1111\/j.1365-2125.2011.04063.x","DOI":"10.1111\/j.1365-2125.2011.04063.x"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF03256359","volume":"14","author":"TJ Hsiao","year":"2010","unstructured":"Hsiao TJ, Wu LS, Hwang Y, Huang SY, Lin E (2010) Effect of the common -866G\/A polymorphism of the uncoupling protein 2 gene on weight loss and body composition under sibutramine therapy in an obese Taiwanese population. Mol Diagn Ther 14:101\u2013106. doi:10.2165\/11532940-000000000-00000","journal-title":"Mol Diagn Ther"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/030079908X253591","volume":"24","author":"S Iannazzo","year":"2008","unstructured":"Iannazzo S, Zaniolo O, Pradelli L (2008) Economic evaluation of treatment with orlistat in Italian obese patients. Curr Med Res Opin 24:63\u201374. doi:10.1185\/030079908X253591","journal-title":"Curr Med Res Opin"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/00002018-200629040-00001","volume":"29","author":"LL Ioannides-Demos","year":"2006","unstructured":"Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ (2006) Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf 29:277\u2013302. doi:2941[pii]","journal-title":"Drug Saf"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL (2010) Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 363:905\u2013917. doi:10.1056\/NEJMoa1003114","journal-title":"N Engl J Med"},{"key":"15_CR64","unstructured":"Jonas D, Van Scoyoc E, Gerrald K, Wines R, Amick H, Triplette M, Runge T (2011) Drug class review: newer diabetes medications, TZDs, and combinations: final original report [Internet]. Oregon Health & Science University, Portland. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21595121"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.2337\/dc09-1634","volume":"32","author":"L Jovanovic","year":"2009","unstructured":"Jovanovic L (2009) Sex differences in insulin dose and postprandial glucose as BMI increases in patients with type 2 diabetes. Diabetes Care 32:e148. doi:10.2337\/dc09-1634","journal-title":"Diabetes Care"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/0091270007300954","volume":"47","author":"A Karim","year":"2007","unstructured":"Karim A, Zhao Z, Slater M, Bradford D, Schuster J, Laurent A (2007) Replicate study design in bioequivalency assessment, pros and cons: bioavailabilities of the antidiabetic drugs pioglitazone and glimepiride present in a fixed-dose combination formulation. J Clin Pharmacol 47:806\u2013816. doi:10.1177\/0091270007300954","journal-title":"J Clin Pharmacol"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/sj.ijo.0802272","volume":"27","author":"J Karlsson","year":"2003","unstructured":"Karlsson J, Taft C, Sj\u00f6str\u00f6m L, Torgerson JS, Sullivan M (2003) Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale. Int J Obes Relat Metab Disord 27:617\u2013630. doi:10.1038\/sj.ijo.0802272","journal-title":"Int J Obes Relat Metab Disord"},{"key":"15_CR68","volume-title":"Sex and gender aspects in clinical medicine","author":"A Kautzky-Willer","year":"2011","unstructured":"Kautzky-Willer A (2011) Sex and gender differences in endocrinology. In: Regitz-Zagrosek V, Oertelt-Prigione S (eds) Sex and gender aspects in clinical medicine, 1st edn. Springer, London","edition":"1"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2362.2009.02161.x","volume":"39","author":"A Kautzky-Willer","year":"2009","unstructured":"Kautzky-Willer A, Handisurya A (2009) Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest 39:631\u2013648. doi:10.1111\/j.1365-2362.2009.02161.x","journal-title":"Eur J Clin Invest"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(09)60222-1","volume":"373","author":"R Kawamori","year":"2009","unstructured":"Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K (2009) Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet 373:1607\u20131614. doi:10.1016\/S0140-6736(09)60222-1","journal-title":"Lancet"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm1061","volume":"10","author":"MS Kim","year":"2004","unstructured":"Kim MS, Park JY, Namkoong C, Jang PG, Ryu JW, Song HS, Yun JY, Namgoong IS, Ha J, Park IS, Lee IK, Viollet B, Youn JH, Lee HK, Lee KU (2004) Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 10:727\u2013733. doi:10.1038\/nm1061","journal-title":"Nat Med"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393\u2013403. doi:10.1056\/NEJMoa012512","journal-title":"N Engl J Med"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"A609","DOI":"10.2337\/db11-2185-2431","volume":"60","author":"L Kosi","year":"2011","unstructured":"Kosi L, Chmelik M, Kautzky-Willer A (2011) Impact of a DPP4-inhibitor on liver and heart lipid content and cardiovascular risk in type 2 diabetic patients. Diabetes 60:A609. doi:10.2337\/db11-2185-2431","journal-title":"Diabetes"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1476-5381.2011.01352.x","volume":"163","author":"G Kunos","year":"2011","unstructured":"Kunos G, Tam J (2011) The case for peripheral CB receptor blockade in the treatment of visceral obesity and its cardiometabolic complications. Br J Pharmacol 163:1423\u20131431. doi:10.1111\/j.1476-5381.2011.01352.x","journal-title":"Br J Pharmacol"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2337\/diabetes.49.6.999","volume":"49","author":"P Kurtzhals","year":"2000","unstructured":"Kurtzhals P, Sch\u00e4ffer L, S\u00f8rensen A, Kristensen C, Jonassen I, Schmid C, Tr\u00fcb T (2000) Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 49:999\u20131005. doi:10.2337\/diabetes.49.6.999","journal-title":"Diabetes"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","volume":"343","author":"O Langer","year":"2000","unstructured":"Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O (2000) A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134\u20131138. doi:10.1056\/NEJM200010193431601","journal-title":"N Engl J Med"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tips.2011.02.013","volume":"32","author":"J Lazary","year":"2011","unstructured":"Lazary J, Juhasz G, Hunyady L, Bagdy G (2011) Personalized medicine can pave the way for the safe use of CB receptor antagonists. Trends Pharmacol Sci 32:270\u2013280. doi:10.1016\/j.tips.2011.02.013","journal-title":"Trends Pharmacol Sci"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.physbeh.2003.07.010","volume":"80","author":"M LeBlanc","year":"2003","unstructured":"LeBlanc M, Thibault L (2003) Effect of sibutramine on macronutrient selection in male and female rats. Physiol Behav 80:243\u2013252. doi:S0031938403002774[pii]","journal-title":"Physiol Behav"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2407-11-20","volume":"11","author":"MS Lee","year":"2011","unstructured":"Lee MS, Hsu CC, Wahlqvist ML, Tsai HN, Chang YH, Huang YC (2011) Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer 11:20. doi:10.1186\/1471-2407-11-20","journal-title":"BMC Cancer"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1365-2125.2009.03453.x","volume":"68","author":"M Li","year":"2009","unstructured":"Li M, Cheung BM (2009) Pharmacotherapy for obesity. Br J Clin Pharmacol 68:804\u2013810. doi:10.1111\/j.1365-2125.2009.03453.x","journal-title":"Br J Clin Pharmacol"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4239\/wjd.v2.i2.19","volume":"2","author":"MF Li","year":"2011","unstructured":"Li MF, Cheung BM (2011) Rise and fall of anti-obesity drugs. World J Diabetes 2:19\u201323. doi:10.4239\/wjd.v2.i2.19","journal-title":"World J Diabetes"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3727\/096504011X13021877989838","volume":"19","author":"A Malki","year":"2011","unstructured":"Malki A, Youssef A (2011) Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling. Oncol Res 19:275\u2013285","journal-title":"Oncol Res"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2147\/VHRM.S6808","volume":"4","author":"MC Mancini","year":"2008","unstructured":"Mancini MC, Halpern A (2008) Orlistat in the prevention of diabetes in the obese patient. Vasc Health Risk Manag 4:325\u2013336. doi:10.2147\/VHRM.S6808","journal-title":"Vasc Health Risk Manag"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.4161\/cc.9.6.10994","volume":"9","author":"B Martin-Castillo","year":"2010","unstructured":"Martin-Castillo B, Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA (2010) Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle 9:1057\u20131064. doi:10994[pii]","journal-title":"Cell Cycle"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/ijo.2011.65","volume":"36","author":"RL McCrea","year":"2011","unstructured":"McCrea RL, Berger YG, King MB (2011) Body mass index and common mental disorders: exploring the shape of the association and its moderation by age, gender and education. Int J Obes (Lond) 36:414\u2013421. doi:10.1038\/ijo.2011.65","journal-title":"Int J Obes (Lond)"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/humrep\/den454","volume":"24","author":"M Metwally","year":"2009","unstructured":"Metwally M, Amer S, Li TC, Ledger WL (2009) An RCT of metformin versus orlistat for the management of obese anovulatory women. Hum Reprod 24:966\u2013975. doi:10.1093\/humrep\/den454","journal-title":"Hum Reprod"},{"key":"15_CR87","first-page":"e165","volume":"16","author":"EM Migoya","year":"2009","unstructured":"Migoya EM, Stevens CH, Bergman AJ, Luo WL, Lasseter KC, Dilzer SC, Davies MJ, Wagner JA, Herman GA (2009) Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin. Can J Clin Pharmacol 16:e165\u2013e170","journal-title":"Can J Clin Pharmacol"},{"key":"15_CR88","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature02440","volume":"428","author":"Y Minokoshi","year":"2004","unstructured":"Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB (2004) AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428:569\u2013574. doi:10.1038\/nature02440","journal-title":"Nature"},{"key":"15_CR89","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1111\/j.1476-5381.2011.01492.x","volume":"164","author":"J Mohapatra","year":"2011","unstructured":"Mohapatra J, Sharma M, Acharya A, Pandya G, Chatterjee A, Balaraman R, Jain MR (2011) Retinol-binding protein 4: a possible role in cardiovascular complications. Br J Pharmacol 164:1939\u20131948. doi:10.1111\/j.1476-5381.2011.01492.x","journal-title":"Br J Pharmacol"},{"key":"15_CR90","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.fertnstert.2010.12.009","volume":"95","author":"G Morgante","year":"2011","unstructured":"Morgante G, Tosti C, Orvieto R, Musacchio MC, Piomboni P, De Leo V (2011) Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome. Fertil Steril 95:2150\u20132152. doi:10.1016\/j.fertnstert.2010.12.009","journal-title":"Fertil Steril"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","volume":"51","author":"N Musi","year":"2002","unstructured":"Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, Zhou G, Williamson JM, Ljunqvist O, Efendic S, Moller DE, Thorell A, Goodyear LJ (2002) Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 51:2074\u20132081. doi:10.2337\/diabetes.51.7.2074","journal-title":"Diabetes"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2337\/dc07-9920","volume":"30","author":"DM Nathan","year":"2007","unstructured":"Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30:753\u2013759. doi:10.2337\/dc07-9920","journal-title":"Diabetes Care"},{"key":"15_CR93","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B (2009) Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 32:193\u2013203. doi:10.2337\/dc08-9025","journal-title":"Diabetes Care"},{"key":"15_CR94","unstructured":"National Collaborating Centre for Women\u2019s and Children\u2019s Health (2008) Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. http:\/\/www.nice.org.uk\/nicemedia\/live\/11946\/41320\/41320.pdf. Accessed 31 Aug 2011"},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","volume":"1","author":"E Nisoli","year":"2000","unstructured":"Nisoli E, Carruba MO (2000) An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action. Obes Rev 1:127\u2013139. doi:10.1046\/j.1467-789x.2000.00020.x","journal-title":"Obes Rev"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/2647","volume":"4","author":"K Nonogaki","year":"1998","unstructured":"Nonogaki K, Strack AM, Dallman MF, Tecott LH (1998) Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nat Med 4:1152\u20131156. doi:10.1038\/2647","journal-title":"Nat Med"},{"key":"15_CR97","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4161\/cc.10.7.15210","volume":"10","author":"C Oliveras-Ferraros","year":"2011","unstructured":"Oliveras-Ferraros C, Cufi S, Vazquez-Martin A, Torres-Garcia VZ, Del Barco S, Martin-Castillo B, Menendez JA (2011) Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFbeta-induced oncomiR miRNA-181a. Cell Cycle 10:1144\u20131151. doi:15210[pii]","journal-title":"Cell Cycle"},{"key":"15_CR98","doi-asserted-by":"publisher","unstructured":"Padwal R, Li SK, Lau DC (2003) Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev: CD004094. 10.1002\/14651858.CD004094","DOI":"10.1002\/14651858.CD004094"},{"key":"15_CR99","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1530\/eje.1.02156","volume":"154","author":"R Pasquali","year":"2006","unstructured":"Pasquali R, Gambineri A (2006) Insulin-sensitizing agents in polycystic ovary syndrome. Eur J Endocrinol 154:763\u2013775. doi:10.1530\/eje.1.02156","journal-title":"Eur J Endocrinol"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/00498250701830267","volume":"38","author":"NN Patel","year":"2008","unstructured":"Patel NN, Crincoli CM, Kennedy EL, Frederick DM, Tchao R, Harvison PJ (2008) Effect of gender, dose, and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats. Xenobiotica 38:435\u2013449. doi:10.1080\/00498250701830267","journal-title":"Xenobiotica"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1463-1326.2009.01133.x","volume":"12","author":"N Perwitz","year":"2010","unstructured":"Perwitz N, Wenzel J, Wagner I, B\u00fcning J, Drenckhan M, Zarse K, Ristow M, Lilienthal W, Lehnert H, Klein J (2010) Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes. Diabetes Obes Metab 12:158\u2013166. doi:10.1111\/j.1463-1326.2009.01133.x","journal-title":"Diabetes Obes Metab"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1161\/01.HYP.22.2.214","volume":"22","author":"JD Peuler","year":"1993","unstructured":"Peuler JD, Johnson BA, Phare SM, Sowers JR (1993) Sex-specific effects of an insulin secretagogue in stroke-prone hypertensive rats. Hypertension 22:214\u2013220","journal-title":"Hypertension"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(10)60307-8","volume":"375","author":"RE Pratley","year":"2010","unstructured":"Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, Thomsen AB, Sondergaard RE, Davies M (2010) Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet 375:1447\u20131456. doi:10.1016\/S0140-6736(10)60307-8","journal-title":"Lancet"},{"key":"15_CR104","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2337\/dc08-0167","volume":"31","author":"AD Rao","year":"2008","unstructured":"Rao AD, Kuhadiya N, Reynolds K, Fonseca VA (2008) Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies. Diabetes Care 31:1672\u20131678. doi:10.2337\/dc08-0167","journal-title":"Diabetes Care"},{"key":"15_CR105","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1210\/jc.2008-0772","volume":"93","author":"RE Ratner","year":"2008","unstructured":"Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE (2008) Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab 93:4774\u20134779. doi:10.1210\/jc.2008-0772","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","volume":"28","author":"C Ravinet Trillou","year":"2004","unstructured":"Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28:640\u2013648. doi:10.1038\/sj.ijo.0802583","journal-title":"Int J Obes Relat Metab Disord"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2337\/dc06-0210","volume":"30","author":"B Richelsen","year":"2007","unstructured":"Richelsen B, Tonstad S, R\u00f6ssner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A (2007) Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Diabetes Care 30:27\u201332. doi:10.2337\/dc06-0210","journal-title":"Diabetes Care"},{"key":"15_CR108","doi-asserted-by":"publisher","unstructured":"Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch CL (2008) Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev: CD006739. 10.1002\/14651858.CD006739.pub2","DOI":"10.1002\/14651858.CD006739.pub2"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2337\/dc09-1203","volume":"33","author":"J Rosenstock","year":"2010","unstructured":"Rosenstock J, Klaff LJ, Schwartz S, Northrup J, Holcombe JH, Wilhelm K, Trautmann M (2010) Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. Diabetes Care 33:1173\u20131175. doi:dc09-1203[pii]10.2337\/dc09-1203","journal-title":"Diabetes Care"},{"key":"15_CR110","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, Battin MR, Moore MP (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358:2003\u20132015. doi:10.1056\/NEJMoa0707193","journal-title":"N Engl J Med"},{"key":"15_CR111","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00125-011-2312-4","volume":"55","author":"R Ruiter","year":"2012","unstructured":"Ruiter R, Visser LE, van Herk-Sukel MP, Coebergh JW, Haak HR, Geelhoed-Duijvestijn PH, Straus SM, Herings RM, Stricker BH (2012) Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia 55:51\u201362. doi:10.1007\/s00125-011-2312-4","journal-title":"Diabetologia"},{"key":"15_CR112","doi-asserted-by":"publisher","unstructured":"Salpeter S, Greyber E, Pasternak G, Salpeter E (2002) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev: CD002967. 10.1002\/14651858.CD002967","DOI":"10.1002\/14651858.CD002967"},{"key":"15_CR113","doi-asserted-by":"publisher","first-page":"432607","DOI":"10.1155\/2011\/432607","volume":"2011","author":"AH Sam","year":"2011","unstructured":"Sam AH, Salem V, Ghatei MA (2011) Rimonabant: from RIO to Ban. J Obes 2011:432607. doi:10.1155\/2011\/432607","journal-title":"J Obes"},{"key":"15_CR114","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/157489008786264014","volume":"3","author":"A Samat","year":"2008","unstructured":"Samat A, Tomlinson B, Taheri S, Thomas GN (2008) Rimonabant for the treatment of obesity. Recent Pat Cardiovasc Drug Discov 3:187\u2013193","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"15_CR115","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1463-1326.2010.01212.x","volume":"12","author":"AJ Scheen","year":"2010","unstructured":"Scheen AJ (2010) Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes Obes Metab 12:648\u2013658. doi:10.1111\/j.1463-1326.2010.01212.x","journal-title":"Diabetes Obes Metab"},{"key":"15_CR116","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2362.2004.01381.x","volume":"34","author":"G Schernthaner","year":"2004","unstructured":"Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM (2004) GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 34:535\u2013542. doi:10.1111\/j.1365-2362.2004.01381.x","journal-title":"Eur J Clin Invest"},{"key":"15_CR117","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1007\/s00125-010-1702-3","volume":"53","author":"G Schernthaner","year":"2010","unstructured":"Schernthaner G, Barnett AH, Betteridge DJ, Carmena R, Ceriello A, Charbonnel B, Hanefeld M, Lehmann R, Malecki MT, Nesto R, Pirags V, Scheen A, Seufert J, Sjoh\u00f6lm A, Tsatsoulis A, DeFronzo R (2010) Is the ADA\/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia 53:1258\u20131269. doi:10.1007\/s00125-010-1702-3","journal-title":"Diabetologia"},{"key":"15_CR118","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/j.1463-1326.2010.01301.x","volume":"12","author":"A Seeringer","year":"2010","unstructured":"Seeringer A, Parmar S, Fischer A, Altissimo B, Zondler L, Lebedeva E, Pitterle K, Roots I, Kirchheiner J (2010) Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics. Diabetes Obes Metab 12:1106\u20131112. doi:10.1111\/j.1463-1326.2010.01301.x","journal-title":"Diabetes Obes Metab"},{"key":"15_CR119","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/j.1464-5491.2007.02221.x","volume":"24","author":"JS Shaw","year":"2007","unstructured":"Shaw JS, Wilmot RL, Kilpatrick ES (2007) Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Diabet Med 24:1160\u20131163. doi:10.1111\/j.1464-5491.2007.02221.x","journal-title":"Diabet Med"},{"key":"15_CR120","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11239-008-0301-3","volume":"28","author":"T Shimazu","year":"2009","unstructured":"Shimazu T, Inami N, Satoh D, Kajiura T, Yamada K, Iwasaka T, Nomura S (2009) Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients. J Thromb Thrombolysis 28:429\u2013435. doi:10.1007\/s11239-008-0301-3","journal-title":"J Thromb Thrombolysis"},{"key":"15_CR121","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.beem.2010.05.002","volume":"24","author":"D Simmons","year":"2010","unstructured":"Simmons D (2010) Metformin treatment for Type 2 diabetes in pregnancy? Best Pract Res Clin Endocrinol Metab 24:625\u2013634. doi:10.1016\/j.beem.2010.05.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"15_CR122","first-page":"525","volume":"142","author":"V Snow","year":"2005","unstructured":"Snow V, Barry P, Fitterman N, Qaseem A, Weiss K (2005) Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med 142:525\u2013531. doi:142\/7\/525[pii]","journal-title":"Ann Intern Med"},{"key":"15_CR123","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/humrep\/deh580","volume":"20","author":"AS S\u00f6nmez","year":"2005","unstructured":"S\u00f6nmez AS, Ya\u015far L, Savan K, Koc S, \u00d6zcan J, Toklar A, Yaz\u0131c\u0131o\u011fu F, Akg\u00fcn A, Sut N (2005) Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome. Hum Reprod 20:175\u2013179. doi:10.1093\/humrep\/deh580","journal-title":"Hum Reprod"},{"key":"15_CR124","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1007\/s00125-011-2190-9","volume":"54","author":"S Suissa","year":"2011","unstructured":"Suissa S, Azoulay L, Dell\u2019aniello S, Evans M, Vora J, Pollak M (2011) Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia 54:2254\u20132262. doi:10.1007\/s00125-011-2190-9","journal-title":"Diabetologia"},{"key":"15_CR125","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/npp.2009.182","volume":"35","author":"PS Talbot","year":"2010","unstructured":"Talbot PS, Bradley S, Clarke CP, Babalola KO, Philipp AW, Brown G, McMahon AW, Matthews JC (2010) Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans. Neuropsychopharmacology 35:741\u2013751. doi:10.1038\/npp.2009.182","journal-title":"Neuropsychopharmacology"},{"key":"15_CR126","doi-asserted-by":"publisher","first-page":"326","DOI":"10.4088\/JCP.09m05283yel","volume":"72","author":"E Tchoukhine","year":"2011","unstructured":"Tchoukhine E, Takala P, Hakko H, Raidma M, Putkonen H, R\u00e4s\u00e4nen P, Terevnikov V, Stenberg JH, Eronen M, Joffe G (2011) Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week open-label extension phase and both phases of a randomized controlled trial. J Clin Psychiatry 72:326\u2013330. doi:10.4088\/JCP.09m05283yel","journal-title":"J Clin Psychiatry"},{"key":"15_CR127","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1055\/s-0031-1280780","volume":"43","author":"JA Teng","year":"2011","unstructured":"Teng JA, Hou RL, Li DL, Yang RP, Qin J (2011) Glargine promotes proliferation of breast adenocarcinoma cell line MCF-7 via AKT activation. Horm Metab Res 43:519\u2013523. doi:10.1055\/s-0031-1280780","journal-title":"Horm Metab Res"},{"key":"15_CR128","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1345\/aph.1M426","volume":"44","author":"S Thayer","year":"2010","unstructured":"Thayer S, Arondekar B, Harley C, Darkow TE (2010) Adherence to a fixed-dose combination of rosiglitazone\/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and\/or a sulfonylurea. Ann Pharmacother 44:791\u2013799. doi:10.1345\/aph.1M426","journal-title":"Ann Pharmacother"},{"key":"15_CR129","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ijcard.2006.03.014","volume":"115","author":"HD Tildesley","year":"2007","unstructured":"Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G (2007) Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes. Int J Cardiol 115:312\u2013317. doi:S0167-5273(06)00402-5[pii]10.1016\/j.ijcard.2006.03.014","journal-title":"Int J Cardiol"},{"key":"15_CR130","first-page":"1091","volume":"10","author":"A Tiwari","year":"2009","unstructured":"Tiwari A (2009) Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. Curr Opin Investig Drugs 10:1091\u20131104","journal-title":"Curr Opin Investig Drugs"},{"key":"15_CR131","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/diacare.27.1.155","volume":"27","author":"JS Torgerson","year":"2004","unstructured":"Torgerson JS, Hauptman J, Boldrin MN, Sj\u00f6str\u00f6m L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27:155\u2013161. doi:10.2337\/diacare.27.1.155","journal-title":"Diabetes Care"},{"key":"15_CR132","unstructured":"U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee (2007) FDA briefing document: Zimulti (rimonabant) Tablets, 20\u00a0mg. http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4306b1-00-index.htm. Accessed 6 Aug 2007"},{"key":"15_CR133","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854\u2013865. doi:S0140673698070378[pii]","journal-title":"Lancet"},{"key":"15_CR134","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1055\/s-0030-1261963","volume":"119","author":"F \u00dclgen","year":"2011","unstructured":"\u00dclgen F, K\u00fchn MC, Cupisti K, Herder C, Willenberg HS, Schott M, Scherbaum WA, Schinner S (2011) The CB-1 receptor antagonist rimonabant modulates the interaction between adipocytes and pancreatic beta-cells in vitro. Exp Clin Endocrinol Diabetes 119:41\u201346. doi:10.1055\/s-0030-1261963","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"15_CR135","first-page":"206","volume":"22","author":"M Varli","year":"2010","unstructured":"Varli M, Turhan S, Aras S, Atli T, Erdogan G (2010) Effects of weight loss on ventricular systolic and diastolic functions and left ventricular mass assessed by tissue doppler imaging in obese geriatric women: preliminary report. Aging Clin Exp Res 22:206\u2013211. doi:7162[pii]","journal-title":"Aging Clin Exp Res"},{"key":"15_CR136","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3892\/or_00001052","volume":"25","author":"A Vazquez-Martin","year":"2011","unstructured":"Vazquez-Martin A, Oliveras-Ferraros C, Cuf\u00ed S, Del Barco S, Martin-Castillo B, Lopez-Bonet E, Menendez JA (2011) The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells. Oncol Rep 25:135\u2013140. doi:10.3892\/or_00001052","journal-title":"Oncol Rep"},{"key":"15_CR137","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1365-2796.2010.02215.x","volume":"268","author":"L Venskutonyte","year":"2010","unstructured":"Venskutonyte L, Malmberg K, Norhammar A, Wedel H, Ryd\u00e9n L (2010) Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes. J Intern Med 268:75\u201382. doi:10.1111\/j.1365-2796.2010.02215.x","journal-title":"J Intern Med"},{"key":"15_CR138","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5414\/CPP44051","volume":"44","author":"MA von Mach","year":"2006","unstructured":"von Mach MA, Gauer M, Meyer S, Omogbehin B, Schinzel H, Kann PH, Weilemann LS (2006) Antidiabetic medications in overdose: a comparison of the inquiries made to a regional poisons unit regarding original sulfonylureas, biguanides and insulin. Int J Clin Pharmacol Ther 44:51\u201356","journal-title":"Int J Clin Pharmacol Ther"},{"key":"15_CR139","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/FBP.0b013e328331ba30","volume":"20","author":"SJ Ward","year":"2009","unstructured":"Ward SJ, Walker EA (2009) Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice. Behav Pharmacol 20:605\u2013613. doi:10.1097\/FBP.0b013e328331ba30","journal-title":"Behav Pharmacol"},{"key":"15_CR140","first-page":"95","volume":"57","author":"J Wassell","year":"2011","unstructured":"Wassell J, Michail M, Soliman N, Wardle PG (2011) The value of sex hormone binding globulin (SHBG) in predicting treatment response in polycystic ovary syndrome (PCOS). Clin Lab 57:95\u201398","journal-title":"Clin Lab"},{"key":"15_CR141","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/oby.2008.224","volume":"16","author":"DS West","year":"2008","unstructured":"West DS, Elaine Prewitt T, Bursac Z, Felix HC (2008) Weight loss of black, white, and Hispanic men and women in the Diabetes Prevention Program. Obesity (Silver Spring) 16:1413\u20131420. doi:10.1038\/oby.2008.224","journal-title":"Obesity (Silver Spring)"},{"key":"15_CR142","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1113\/jphysiol.2006.113217","volume":"574","author":"B Xue","year":"2006","unstructured":"Xue B, Kahn BB (2006) AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol 574:73\u201383. doi:10.1113\/jphysiol.2006.113217","journal-title":"J Physiol"},{"key":"15_CR143","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ygyno.2011.02.021","volume":"121","author":"A Yasmeen","year":"2011","unstructured":"Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M, Gotlieb WH (2011) Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecol Oncol 121:492\u2013498. doi:10.1016\/j.ygyno.2011.02.021","journal-title":"Gynecol Oncol"},{"key":"15_CR144","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/IGC.0b013e318207dac7","volume":"21","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Dong L, Sui L, Yang Y, Liu X, Yu Y, Zhu Y, Feng Y (2011) Metformin reverses progestin resistance in endometrial cancer cells by downregulating GloI expression. Int J Gynecol Cancer 21:213\u2013221. doi:10.1097\/IGC.0b013e318207dac7","journal-title":"Int J Gynecol Cancer"},{"key":"15_CR145","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cmet.2007.10.008","volume":"6","author":"L Zhou","year":"2007","unstructured":"Zhou L, Sutton GM, Rochford JJ, Semple RK, Lam DD, Oksanen LJ, Thornton-Jones ZD, Clifton PG, Yueh CY, Evans ML, McCrimmon RJ, Elmquist JK, Butler AA, Heisler LK (2007) Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab 6:398\u2013405. doi:10.1016\/j.cmet.2007.10.008","journal-title":"Cell Metab"},{"key":"15_CR146","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000324582","volume":"4","author":"A Zulian","year":"2011","unstructured":"Zulian A, Cancello R, Girola A, Gilardini L, Alberti L, Croci M, Micheletto G, Danelli P, Invitti C (2011) In vitro and in vivo effects of metformin on human adipose tissue adiponectin. Obes Facts 4:27\u201333. doi:10.1159\/000324582","journal-title":"Obes Facts"}],"container-title":["Handbook of Experimental Pharmacology","Sex and Gender Differences in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-30726-3_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T11:05:08Z","timestamp":1675940708000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-30726-3_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,5]]},"ISBN":["9783642307256","9783642307263"],"references-count":146,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-30726-3_15","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2012,9,5]]},"assertion":[{"value":"5 September 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}